Goldman Sachs raises SCA’s share price target — 5 facts

Goldman Sachs analysts raised Surgical Care Affiliates’ price target from $46 to $49, according to Intercooler.

Advertisement

Here are five facts:

1. The analysts’ price objectives indicate a potential upside of nearly 19 percent from SCA’s current price.

2. On Feb. 3, SCA shares fell 1.63 percent, hitting $41.06.

3. SCA has a market cap of $1.63 billion and a P/E ratio of 12..61

4. The company has a 50-day moving average of $40.89 and 200-day moving average of $36.75.

5. The 52-week low is $27.88 and 52-week high is $45.11.

More articles on surgery centers:
Should your ASC go it alone? Pinnacle III CEO Rob Carrera on ASC independence
8 recent ASC acquisitions — Feb. 5, 2016
Hospital for Special Surgery opens new outpatient center in Westchester County — 5 points

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.